NCT03297762 is a NA clinical trial of gamification in Type1diabetes, sponsored by Stanford University.

Who is sponsoring NCT03297762?

NCT03297762 is sponsored by Stanford University.

What drugs are being tested in NCT03297762?

Interventions in NCT03297762: gamification, Use of Dexcom G5.

What condition does NCT03297762 study?

NCT03297762 studies Type1diabetes.

Is NCT03297762 still recruiting?

NCT03297762 is currently terminated. Last updated 20 April 2020.

Last reviewed 2020-04-20 · How we verify

NCT03297762

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Terminated NA Last updated 20 April 2020

What this trial tests

NA trial testing gamification in Type1diabetes in 4 participants. Terminated before completion.

Timeline

7 May 2018

Primary endpoint
1 May 2019

1 June 2019

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	4
Start date	7 May 2018
Primary completion	1 May 2019
Estimated completion	1 June 2019
Sites	1 location across United States

Drugs / interventions tested

gamification
Use of Dexcom G5

Conditions studied

Type1diabetes — all drugs for Type1diabetes →

Sponsor

Stanford University

Who can join

Adults 13 to 19, any sex, with Type1diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

NCT07139808 — Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System · NA · recruiting
NCT07092761 — Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System · NA · recruiting
NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
NCT06753994 — Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors · Phase 1 · recruiting
NCT05668507 — REACHOUT Mental Health Support Mobile App · NA · active not recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03297762 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 20 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03297762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing